Grifols

Grifols(GIKLY)

NEW YORK, NY
Diagnostics1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Diagnostics, Plasma Derivatives

Grifols is a life sciences company focused on Diagnostics, Plasma Derivatives.

Rare Diseases
Funding Stage
PUBLIC
Open Jobs
0

Products & Portfolio (1)

SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
Post-LOE
INJECTION · INJECTABLE
2017
30

Pipeline & Clinical Trials

Use of the test for treatment optimization
Crohn Disease and Ulcerative Colitis
N/A
Clinical Trials (1)
NCT06666569Evaluation of the Effectiveness of Kits Promonitor-IFX/ADL and Promonitor-Anti-IFX/ADL in Patients With IBD
N/A
N/A
Clinical Trials (1)
NCT07152834Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction
N/A
FVIII Concentrates
Severe Hemophilia A
N/A
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
Septic Shock
N/A
Clinical Trials (1)
NCT05094856Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
N/A
Human rabies immune globulin 300 IU/mL
Rabies
N/A
Clinical Trials (1)
NCT05382650Survey of Human Rabies Immune Globulin Safety in Children
N/A
Gamimune N or Gamunex 10%
Miscarriage, Recurrent
N/A
Clinical Trials (1)
NCT00606905Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage
N/A
N/A
Clinical Trials (1)
NCT02043379Post-bypass Prophylactic IVIG in Infants and Neonates
N/A
20% Albumin
Sepsis, Severe
N/A
Clinical Trials (1)
NCT05357339Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock
N/A
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correl
Multifocal Motor Neuropathy (MMN)
N/A
Clinical Trials (1)
NCT04356781Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
N/A
VWF/FVIII concentrates
Severe Hemophilia A
N/A
Rabies PEP quality improvement bundle
Rabies
N/A
Clinical Trials (1)
NCT04213950Improving Adherence to Rabies PEP Guideline Recommendations
N/A
ITP Registry and Accompanying Biospecimen Collection
Immune Thrombocytopenia
N/A
Plasma exchange with albumin
Liver Cirrhosis
N/A
Clinical Trials (1)
NCT01201720Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"
N/A
collection of sputum
Alpha-1 Antitrypsin Deficiency
N/A
Clinical Trials (1)
NCT02547532Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency
N/A
N/A
Clinical Trials (1)
NCT02878733Albumin Administration and Outcomes in Cardiac Surgery
N/A
N/A
Clinical Trials (1)
NCT01380626Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients
N/A
Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab
Autoimmune Diseases
N/A
Clinical Trials (1)
NCT03778840Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab
N/A
N/A
Clinical Trials (1)
NCT01505946Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors
N/A
Phase 1
Clinical Trials (1)
NCT02631174Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support
Phase 1
Antithrombin III
Portal Vein Thrombosis
Phase 1
Clinical Trials (1)
NCT04055389Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
Phase 1
Phase 1
Clinical Trials (1)
NCT00418483A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion
Phase 1
Phase 1
Clinical Trials (1)
NCT01841619IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Phase 1
RIG-C
Rabies
Phase 1
Clinical Trials (1)
NCT02139657An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human)
Phase 1
Phase 1/2
Clinical Trials (1)
NCT04722887A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency
Phase 1/2
Human Plasma-Derived Fibrinogen Concentrate
Congenital Afibrinogenemia
Phase 1/2
Clinical Trials (1)
NCT02281500Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT02870348Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT01014975A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT02870309Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency
Phase 1/2
Immune Globulin Intravenous
Sickle Cell Disease
Phase 1/2
Clinical Trials (1)
NCT01757418Intravenous Gammaglobulin for Sickle Cell Pain Crises
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT03919773IVIG (Gamunex-C) Treatment Study for POTS Subjects
Phase 1/2
Thrombate infusion
Trauma Injury
Phase 2
Clinical Trials (1)
NCT05794165Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
Phase 2
25% IV albumin
Cirrhosis
Phase 2
Clinical Trials (1)
NCT03585257HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
Phase 2
Phase 2
Clinical Trials (1)
NCT02479802Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis
Phase 2
Phase 2
Clinical Trials (1)
NCT02473965Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Phase 2
Phase 2
Clinical Trials (1)
NCT02872142Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis
Phase 2
Phase 2
Clinical Trials (1)
NCT00115778Intravenous Immunoglobulin (IVIG) in Lung Transplantation
Phase 2
Phase 2
Clinical Trials (1)
NCT02037555Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass
Phase 2
Phase 2
Clinical Trials (1)
NCT04899232Antithrombin III in Infectious Disease Caused by COVID-19
Phase 2
Alpha1-Proteinase Inhibitor
Alpha 1-Antitrypsin Deficiency
Phase 2
Clinical Trials (1)
NCT00263887Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)
Phase 2
180 mg/kg Alpha1-PI
Type 1 Diabetes Mellitus
Phase 2
Clinical Trials (1)
NCT02093221Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Phase 2
Liquid Alpha1-Proteinase Inhibitor
COVID-19
Phase 2
Clinical Trials (1)
NCT04547140Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
Phase 2
Phase 2
Clinical Trials (1)
NCT02915263The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
Phase 2
Albumin Infusion
Cirrhosis
Phase 2
Clinical Trials (1)
NCT06052176Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
Phase 2
Convalescent anti-SARS-CoV-2 MBT plasma
SARS-CoV-2 Infection
Phase 2
Clinical Trials (1)
NCT04621123Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients
Phase 2
Phase 2
Clinical Trials (1)
NCT02473952A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
Phase 2
Phase 2
Clinical Trials (1)
NCT03095287Alphanate in Immune Tolerance Induction Therapy
Phase 2
intramuscular hepatitis B virus immune globulin
Hepatitis B, Chronic
Phase 2
Clinical Trials (1)
NCT00895713Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation
Phase 2
Phase 2
Clinical Trials (1)
NCT01222117A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Phase 2
Human thrombin
Hemostasis
Phase 2
Clinical Trials (1)
NCT02014402Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery
Phase 2
Albumin infusion
Cirrhosis
Phase 2
Clinical Trials (1)
NCT06812390Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 1909
Portfolio: 1 approved product, 47 clinical trials
H-1B (2023): 1 approval
Portfolio Health
Post-LOE1 (100%)
1 total products

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub